M&A Deal Summary

Qiagen N.V Acquires DxS

On September 22, 2009, Qiagen N.V acquired healthcare services company DxS from NVM Private Equity and YFM Equity Partners for 130M USD

Acquisition Highlights
  • This is Qiagen N.V’s 1st transaction in the Healthcare Services sector.
  • This is Qiagen N.V’s 4th largest (disclosed) transaction.
  • This is Qiagen N.V’s 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2009-09-22
Target DxS
Sector Healthcare Services
Buyer(s) Qiagen N.V
Sellers(s) NVM Private Equity
YFM Equity Partners
Deal Type Add-on Acquisition
Deal Value 130M USD

Target

DxS

Manchester, United Kingdom
DxS Ltd. is a personalized healthcare company providing molecular diagnostics to aid doctors and drug companies in selecting safe and effective therapies for patients based on their molecular profiles (Companion diagnostics). DxS was formed in 2001 and is headquartered in Manchester, UK.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Qiagen N.V

Venlo, Netherlands
Category Company
Founded 1984
Sector Life Science
Employees5,200
Revenue 1.5B USD (2019)
DESCRIPTION

QIAGEN N.V. is a Netherlands holding company publically traded on NASDAQ and Frankfurt Prime Standard. The Company is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular insights. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). Qiagen was founded in 1986 and is based in Venlo, the Netherlands.

DEAL STATS #
Overall 6 of 16
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 5 of 15
Country (United Kingdom) 1 of 1
Year (2009) 1 of 2
Size (of disclosed) 4 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-10-01 Biotage - Biosystems Business

United States

Buy $53M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-12-14 SABiosciences

Frederick, Maryland, United States

SABiosciences Corp. is a provider of biological research in the post-genomic era.

Buy -

Seller(S) 2

SELLER

NVM Private Equity

Newcastle Upon Tyne, United Kingdom

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1984
PE ASSETS 290M GBP
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

NVM Private Equity is an investor in growth-oriented UK-based companies. NVM does not have any sector preferences and looks to invest £2 to £10 million equity per transaction. NVM will consider a variety of transaction situations, including MBOs, MBIs, development capital financings, turnarounds, recapitalizations and early stage financings. NVM Private Equity was established in 1984 and was formerly known as Northern Venture Managers Ltd. NVM is based in Newcastle with additional offices in Edinburgh, Manchester, and Reading.

DEAL STATS #
Overall 1 of 37
Sector (Healthcare Services) 1 of 2
Type (Add-on Acquisition) 1 of 17
Country (United Kingdom) 1 of 37
Year (2009) 1 of 2
Size (of disclosed) 1 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-10-06 CloserStill

London, United Kingdom

CloserStill is a provider in business trade show operator focusing on the healthcare, learning, and technology, and veterinary sectors. CloserStill was founded in 2008 and is based in London, England.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-11-17 Abermed

Aberdeen, United Kingdom

Abermed Limited provides medical and health services in the United Kingdom and internationally.

Sell -
SELLER

YFM Equity Partners

Leeds, United Kingdom

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1982
PE ASSETS 300M GBP
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

YFM Equity Partners is a private equity firm focused on growth oriented investments in UK-based companies. The Firm looks to invest up to £10 million to support a variety of established, growing, and profitable businesses. YFM Equity Partners was formed in 1982 and is based in Leeds, England.

DEAL STATS #
Overall 12 of 49
Sector (Healthcare Services) 1 of 5
Type (Add-on Acquisition) 10 of 34
Country (United Kingdom) 12 of 48
Year (2009) 3 of 3
Size (of disclosed) 3 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-04-08 Tepnel Life Sciences

Wythenshawe, United Kingdom

Tepnel Life Sciences is a UK-based international life sciences products and services group with two divisions, Molecular Diagnostics and Research Products & Services.

Sell £93M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-12-21 Deep Secure

Malvern, United Kingdom

Founded in 2009 and headquartered in the U.K., Deep Secure’s cybersecurity products and services give organizations immunity from cyberattacks delivered via malware and help protect against covert data loss. It delivers ubiquitous information safety for a hyper-connected digital age and will improve the lives of billions of people.

Buy £4M
Mergr

Product

Company

Legal